Steve Kay

Former President at The Scripps Research Institute

Steve Kay

Steve Kay

Former President at The Scripps Research Institute

Overview
Career Highlights

University of Southern California - Dana and David Dornsife College of Letters, Arts and Sciences
The Scripps Research Institute
Phenomix Corp.

RelSci Relationships

6103

Number of Boards

13

Number of Awards

1

Relationships
RelSci Relationships are individuals Steve Kay likely has professional access to. A relationship does not necessarily indicate a personal connection.

President & Chief Executive Officer at The Scripps Research Institute

Relationship likelihood: Strong

Acting President at University of Southern California

Relationship likelihood: Strong

Co-Founder at Ajinomoto Althea, Inc.

Relationship likelihood: Strong

Provost Professor of Biological Sciences & Biomedical Engineering at Children's Hospital Los Angeles

Relationship likelihood: Strong

Vice Provost, Graduate Programs & Professor of Slavic Languages & Literatures at University of Southern California - Dana and David Dornsife College of Letters, Arts and Sciences

Relationship likelihood: Strong

Former Director at Chiron Corp.

Relationship likelihood: Strong

Provost Professor of Biological Sciences & Chemistry at University of Southern California - Dana and David Dornsife College of Letters, Arts and Sciences

Relationship likelihood: Strong

Vice President, Chief Scientific Officer & Director, the Saban Research Institute at Children's Hospital Los Angeles

Relationship likelihood: Strong

Professor at University of Southern California

Relationship likelihood: Strong

Non-Resident Fellow at The Salk Institute for Biological Studies

Relationship likelihood: Strong

Paths to Steve Kay
Potential Connections via
Relationship Science
You
Steve Kay
Former President at The Scripps Research Institute
Education
Ph.D.

The University of Bristol is a red brick research university that offers a range of educational courses and services. The university is organized into six academic facilities: Faculty of Arts, Faculty of Engineering, Faculty of Medical and Veterinary Sciences, Faculty of Science, Faculty of Medicine and Dentistry, and Faculty of Social Sciences and Law. These faculties together award a range of academic degrees spanning bachelor's and master's degrees as well as junior doctorates and higher doctorates. University of Bristol was established in 1876 and is based in Bristol, United Kingdom.

Memberships
Fellow
2009 - Current

The American Association for the Advancement of Science provides science related journal, program, and education services. The firm also promotes the responsible use of science in public policy. The company was founded in 1848 and is headquartered in Washington, DC.

Member
2008 - Current

The National Academy of Sciences (NAS) formed the Committee on International Security and Arms Control (CISAC) in 1980 as a permanent committee to bring the resources of the Academy to bear on critical problems of international security and arms control. CISAC, in the Policy and Global Affairs Division, draws from the nation’s finest scientific, technical, engineering and medical talent to advise the government, contribute to the work of non-governmental organizations, and inform the public about scientific and technical issues related to international security and arms control. CISAC’s work benefits from a rotating membership of distinguished scientists, policy and military experts. The Committee carries out its mandate through a variety of activities that receive financial support from public and private sponsors.

Career History
President
Current

The Scripps Research Institute (TSRI), one of the world's largest, private, non-profit research organizations, stands at the forefront of basic biomedical science, a vital segment of medical research that seeks to comprehend the most fundamental processes of life. Over the last decades, the institute has established a lengthy track record of major contributions to the betterment of health and the human condition. The institute — which is located on campuses in La Jolla, California, and Jupiter, Florida — has become internationally recognized for its research into immunology, molecular and cellular biology, chemistry, neurosciences, autoimmune diseases, cardiovascular diseases, virology, and synthetic vaccine development. Particularly significant is the institute's study of the basic structure and design of biological molecules; in this arena TSRI is among a handful of the world's leading centers. The institute’s educational programs are also top-rate. The Kellogg School of Science and Technology is currently ranked among the best in the nation in its fields of biology and chemistry. Rather than isolating faculty members, students, and laboratories into separate and distinct disciplines, as is generally prescribed in universities, a cooperative, collaborative spirit is encouraged and embraced. While the level of scientific investigation is intense, the atmosphere is collegial, relaxed, and informal. Technicians, postdoctoral fellows, graduate students, and administrative support staff all are considered part of the team and are given the latitude and responsibility to accomplish their tasks so as to serve the best interests of science. The pursuit of scientific excellence is paramount and all efforts are directed toward that end. The bulk of the institute's funding is derived from the National Institutes of Health and other federal agencies. In today's environment of increasing competition for shrinking federal dollars, however, collaborative industrial partnerships with leading pharmaceutical companies provide additional funding in several areas key to the organization's research objectives. The Scripps Research Institute's adherence to the highest scientific standards, emphasis on a multidisciplinary approach to problem solving, participation in the perpetuation of knowledge through education, and continual pursuit of research excellence provide an unparalleled scientific environment.

Provost Professor of Neurology, Biomedical Engineering & Biological Sciences
2012 - Current

The USC Dana and David Dornsife College of Letters, Arts and Sciences, the oldest and largest of the USC schools, grants undergraduate degrees in more than 130 majors and minors across the humanities, social sciences, and natural/physical sciences, and offers doctoral and masters programs in more than 20 fields. In 2011, the college changed its name from College of Letters, Arts and Sciences to the USC Dana and David Dornsife College of Letters, Arts and Sciences.

Head, Michelson Center for Convergent Bioscience
Current

University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA.

Boards & Committees
Director
2017 - Current

California Biomedical Innovation Alliance is a private company headquartered in South San Francisco, CA, that provides biomedical advocacy and community services. Sara Radcliffe is currently the CEO of the firm.An excerpt from the company's website reads as follows: California Life Sciences Association (CLSA) is the state's largest and most influential life sciences advocacy and business leadership organization. With offices in Sacramento, San Diego, South San Francisco, Los Angeles and Washington DC, CLSA works closely with industry, government, academia and others to shape public policy, improve access to innovative technologies and grow California's life sciences economy. CLSA serves bio technology, pharmaceutical, medical device and diagnostics companies, research universities and institutes, investors and service providers throughout the Golden State. CLSA was founded in 2015 when the Bay Area Bioscience Association (BayBio) and the California Healthcare Institute (CHI) merged.

Member, Board of Directors
Current

Reset Therapeutics, Inc. discovers, develops and commercializes novel therapeutics. Its products identify components of the circadian system that can be targeted to treat metabolic and related disorders, such as diabetes, obesity, and cardiovascular diseases. The company was founded by Ross S. Bersot, Joseph S. Takahashi, Masashi Yanagisawas and Ron Evans in 2008 and is headquartered in San Jose, CA.

Member, Advisory Board
Tenure Unconfirmed

Toyota Motor Corp. engages in the manufacture and sale of motor vehicles and parts. It operates through the following segments: Automotive Operations, Financial Services, and All Other. The Automotive Operations segment designs, manufactures, assembles and sells passenger cars, minivans, trucks, and related vehicle parts and accessories. It is also involved in the development of intelligent transport systems. The Financial Services segment offers purchase or lease financing to Toyota vehicle dealers and customers. It also provides retail leasing through lease contracts purchase by dealers. The All Others segment deals with the design and manufacture and sale of housing, telecommunications and other businesses. The company was founded by Kiichiro Toyoda on August 28, 1937 and is headquartered in Toyota, Japan.

Member, Board of Directors
2017 - Current

BIOCOM provides scientific and technological services. The firm focuses that positively influence the growth of the life science industry, including capital formation, public policy, workforce development and scientific discovery and development. The company was founded in 1995 and is headquartered in San Diego, CA.

Member, Board of Directors
Prior - 2018

San Diego Natural History Museum operates as a premier collections-based environmental education and natural history research resource. The company was founded in 1874 and is headquartered in San Diego, CA.

Member, Board of Trustees
Prior - 2016

The Scripps Research Institute (TSRI), one of the world's largest, private, non-profit research organizations, stands at the forefront of basic biomedical science, a vital segment of medical research that seeks to comprehend the most fundamental processes of life. Over the last decades, the institute has established a lengthy track record of major contributions to the betterment of health and the human condition. The institute — which is located on campuses in La Jolla, California, and Jupiter, Florida — has become internationally recognized for its research into immunology, molecular and cellular biology, chemistry, neurosciences, autoimmune diseases, cardiovascular diseases, virology, and synthetic vaccine development. Particularly significant is the institute's study of the basic structure and design of biological molecules; in this arena TSRI is among a handful of the world's leading centers. The institute’s educational programs are also top-rate. The Kellogg School of Science and Technology is currently ranked among the best in the nation in its fields of biology and chemistry. Rather than isolating faculty members, students, and laboratories into separate and distinct disciplines, as is generally prescribed in universities, a cooperative, collaborative spirit is encouraged and embraced. While the level of scientific investigation is intense, the atmosphere is collegial, relaxed, and informal. Technicians, postdoctoral fellows, graduate students, and administrative support staff all are considered part of the team and are given the latitude and responsibility to accomplish their tasks so as to serve the best interests of science. The pursuit of scientific excellence is paramount and all efforts are directed toward that end. The bulk of the institute's funding is derived from the National Institutes of Health and other federal agencies. In today's environment of increasing competition for shrinking federal dollars, however, collaborative industrial partnerships with leading pharmaceutical companies provide additional funding in several areas key to the organization's research objectives. The Scripps Research Institute's adherence to the highest scientific standards, emphasis on a multidisciplinary approach to problem solving, participation in the perpetuation of knowledge through education, and continual pursuit of research excellence provide an unparalleled scientific environment.

Member, Advisory Board
Prior

Monsanto Co. engages in the provision of agricultural products to farmers. The firm operates its business through the following business segments: Seeds & Genomics and Agricultural Productivity. The Seeds & Genomics segment produces seed brands, including DEKALB, Asgrow, Deltapine, Seminis and De Ruiter and develops biotechnology traits that assist farmers in controlling insects and weeds. The Agricultural Productivity segment manufactures Roundup and Harness brand herbicides and other herbicides. It also provides other seed companies with genetic material and biotechnology traits for their seed brands. The company was founded by John F. Queeny in 1901 and is headquartered in St. Louis, MO.

Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
N/A
2009

The American Association for the Advancement of Science provides science related journal, program, and education services. The firm also promotes the responsible use of science in public policy. The company was founded in 1848 and is headquartered in Washington, DC.

Investments
Details Hidden

Phenomix Corp. is a biopharmaceutical company focused on the discovery, development and commercialization of novel small-molecule product candidates directed toward clinically validated targets in significant therapeutic markets. It's internally discovered product candidates are designed to have improved efficacy, safety or convenience relative to existing therapies and other product candidates in clinical development. Its lead product candidate, dutogliptin tartrate, is a dipeptidyl peptidase-4, or DPP-4, inhibitor that it is developing as an oral, once-daily treatment for Type 2 diabetes. Its Phase 2b clinical trial of dutogliptin demonstrated statistically significant reductions in HbA1c when administered in combination with existing drugs for the treatment of Type 2 diabetes. The company commenced its Phase 3 clinical program in the third quarter of 2008. Its second product candidate, PHX1766, is a protease inhibitor currently in Phase 1 of clinical development for the treatment of hepatitis C virus, or HCV, infection.The company intends to maximize the value of its product candidates through independent development, licensing and other partnership opportunities. These may include co-development or co-marketing agreements, licensing agreements with pharmaceutical and biotechnology companies that possess established development and commercialization capabilities or direct commercialization by building its own sales and marketing force.

Awards & Honors
2012
University of Southern California, College of Letters, Arts & Sciences - Anna H. Bing Dean’s Chair
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Steve Kay. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Steve Kay's profile does not indicate a business or promotional relationship of any kind between RelSci and Steve Kay.
  • be_ixf; php_sdk; php_sdk_1.4.15
  • https://relationshipscience.com/person/steve-kay-3739944
  • https://relationshipscience.com/person/steve-kay-3739944